Tuberculosis stats drive search for new drugs
Glaxo and TB Alliance team up to replace old treatments. Pharmaceutical companies have pledged to redouble their efforts to find
Glaxo and TB Alliance team up to replace old treatments. Pharmaceutical companies have pledged to redouble their efforts to find
Program Commits to Affordable Pricing New York/London – March 21, 2005 – The Global Alliance for TB Drug Development (TB
The TB Alliance Board of Directors recently welcomed new members: Dr. Bruce Carter, Dr. Lee Reichman and Mr. Parag Saxena
“Investment in the development of new tools (diagnostics, drugs, and vaccines), followed by the rapid introduction of new tools in
Dr. Martien Borgdorff has recently been appointed Executive Director of the KNCV Tuberculosis Foundation, a founding TB Alliance Stakeholder and
Neglected diseasesFew readers of the BMJ were probably aware or even cared that the presidency of the EU Council was
New York/Amsterdam – February 3, 2005 – The Department of Development Cooperation of the Netherlands Ministry of Foreign Affairs (DGIS),
JOHANNESBURG, 4 Jan 2005 (IRIN) – In the crowded wards of African hospitals, coughs and bony bodies tell the story
Scientists are making progress on TB—again. For a disease that scientists conquered 40 years ago, tuberculosis has made an astonishing